Skip directly to content

FDA soy health claim consultation: ENSA-EUVEPRO submit joint comments

on Mon, 03/19/2018 - 10:08

ENSA and EUVEPRO, as key stakeholder associations in soyfoods and in soy protein ingredients, call for the continued approval of a “Soy Protein and Coronary Heart Disease” authorized health claim in the United States, and have submitted joint comments to the FDA consultation.